References
- Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347–1360
- Gao Y, Chen G, Tian H, et al. Prevalence of hypertension in China: A cross-sectional study. PLoS One. 2013;8:e65938
- Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913
- He FJ, MacGregor GA. Cost of poor blood pressure control in the UK: 62, 000 unnecessary deaths per year. J Hum Hypertens. 2003;17:455–457
- He J, Gu D, Chen J, et al. Premature deaths attributable to blood pressure in China: A prospective cohort study. Lancet. 2009;374:1765–1772
- Lawes CM, Vander Hoorn S, Rodgers A, et al. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–1518
- Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811–1821
- Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: Effects on the cardiovascular system. Circulation. 2007;116:85–97
- Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
- Chien KL, Hsu HC, Sung FC, et al. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis. 2005;183:147–155
- Moriarity JT, Folsom AR, Iribarren C, et al. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 2000;10:136–143
- Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study. Arch Intern Med. 2004;164:1546–1551
- Department of Health and Human Services: The International Classification of Diseases, 9th Revision, Clinical Modification: ICD-9-CM, 3rd edition. Washington, DC: Government Printing Office; 1989
- Gu P, Jiang W, Cheng M, et al. Glucose metabolism in outpatients with new-onset hypertension in Chinese Han population. Clin Exp Hypertens. 2012;34:474–481
- Cao Y, Li W, Yang G, et al. Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: A comparison between 1990–1991 and 2009–2010. Int Urol Nephrol. 2012;44:1269–1276
- Zheng L, Sun Z, Zhang X, et al. The association between glomerular filtration rate and stroke in hypertensive patients in rural areas of China. J Hypertens. 2012;30:901–907
- Tavil Y, Kaya MG, Oktar SO, et al. Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis. 2008;197:159–163
- Leoncini G, Viazzi F, Rosei EA, et al. Chronic kidney disease in hypertension under specialist care: The I-DEMAND study. J Hypertens. 2010;28:156–162
- Keenan RT, Pillinger MH. Hyperuricemia, gout, and cardiovascular disease – An important “muddle”. Bull NYU Hosp Jt Dis. 2009;67:285–290
- Nakagawa T, Cirillo P, Sato W, et al. The conundrum of hyperuricemia, metabolic syndrome, and renal disease. Intern Emerg Med. 2008;3:313–318